Altura, BM & Altura, BT (1995) Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherosclerosis. Cellular and Molecular Biology Research 41, 347–359.
Altura, BM, Altura, BT, Gebrewold, A, Ising, H & Gunther, T (1984) Magnesium deficiency and hypertension: correlation between magnesium deficient diets and microcirculatory changes in situ. Science 223, 1315–1317.
Altura, BM, Altura, BT, Gebrewold, A, Ising, H & Gunther, T (1992) Noise-induced hypertension and magnesium in rats: relationship to microcirculation and calcium. Journal of Applied Physiology 72, 194–202.
Anand-Srivastava, MB (1997) Atrial natriuretic peptide-C receptor and membrane signaling in hypertension. Journal of Hypertension 15, 815–826.
Anand-Srivastava, MB, de Champlain, J & Thibault, C (1993) DOCA-salt hypertensive rat hearts exhibit altered expression of G-proteins. American Journal of Hypertension 6, 72–75.
Anand-Srivastava, MB & Trachte, GJ (1993) Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacological Reviews 45, 455–497.
Anderson, EA, Hoffman, RP & Balon, TW (1991) Hyperinsulinemia produced both sympathetic neural activation and vasodilation in normal humans. Journal of Clinical Investigation 87, 2246–2252.
Appel, LJ, Moore, TJ, Obrzanek, E, Vollmer, WM, Svetskey, LP, Sacks, FM, Bray, GA, Vogt, TM, Cutlet, JA, Windhauser, MM, Lin, P-H & Karanja, N (1997) DASH Collaborative Research Group: a clinical trial of the effects of dietary patterns on blood pressure. New England Journal of Medicine 336, 1117–1124.
Arvola, P, Ruskoaho, H & Portsi, I (1993) Effects of high calcium diet on arterial smooth muscle functions and electrolyte balance in mineralo-corticoid-salt hypertensive rat. British Journal of Pharmacology 106, 948–958.
Ascherio, A, Rimm, EB & Giovannuchi, EL (1992) A prospective study of nutritional factors and hypertension among US men. Circulation 86, 1475–1484.
Ascherio, A, Rimm, EB, Hernan, MA, Giovannuchi, EL, Kawachi, I, Stampfer, MJ & Willett, WC (1998) Intake of potassium, magnesium, calcium and fibre and risk of stroke among US men. Circulation 98, 1198–1204.
Auwerx, J, Bouillon, R & Kesteloot, H (1992) Relation between 25,hydroxyvitamin D3, apolipoprotein cholesterol. Arteriosclerosis and Thrombosis 14, 671–674.
Ayback, M, Sermet, A, Ayyilidiz, MO & Karakilcik, AZ (1995) Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Drug Research 45, 1271–1273.
Baksi, SN, Abhold, RH & Speth, RC (1989) Low calcium diet increases blood pressure and alters peripheral but not central angiotensin II binding sites in rats. Journal of Hypertension 7, 423–427.
Balarajan, R, Yuen, P & Machin, D (1987) Inequalities in health: changes in RHA's in the past decade. British Medical Journal 294, 1561–1564.
Barbagallo, M, Dominguez, LJ, Tagliamonte, MR, Resnick, LM & Paolisso, G (1999) Effects of vitamin E and glutathione on glucose metabolism. Role of magnesium. Hypertension 34, 1002–1006.
Barger-Lux, MJ & Heaney, RP (1994) The role of calcium intake in preventing bone fragility, hypertension and certain cancers. Journal of Nutrition 124, 1406S–1411S.
Bates, CJ, Prentice, A, Cole, TJ, Van der Pols, JC, Doyle, W, Finch, S, Smithers, G & Clarke, PC (1999) Micronutrients: highlights and research challenges from the 1994–5 National Diet and Nutrition Survey of people aged 65 years and over. British Journal of Nutrition 82, 7–15.
Belizan, JM & Villar, J (1980) The relationship between calcium intake and edema, proteinuria and hypertension-gestosis: an hypothesis. American Journal of Clinical Nutrition 33, 2202–2210.
Belizan, JM, Villar, J, Gonzalez, L, Campodonico, L & Bergal, E (1991) Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine 325, 1399–1405.
Bender, DA (1999) Non-nutritional uses of vitamin B6. British Journal of Nutrition 81, 7–20.
Bender, DA & Totoe, L (1984) High doses of vitamin B6 are associated with inhibition of hepatic tryptophan metabolism and increased uptake of tryptophan into the brain. Journal of Neurochemistry 43, 269–275.
Berthelot, A & Esposito, J (1983) Effects of dietary magnesium on the development of hypertension in the spontaneously hypertensive rat. Journal of the American College of Nutrition 4, 345–353.
Boarder, MR & Hourani, SMO (1998) The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends in Pharmacological Science 19, 99–107.
Boucher, BJ (1998) Inadequate vitamin D status: does it contribute to the disorders comprising syndrome “x”? British Journal of Nutrition 79, 315–327.
Brickman, AS, Nyby, MD, von Hungen, K, Eggena, P & Tuck, ML (1990) Calcitropic hormones, platelet calcium and blood pressure in essential hypertension. Hypertension 16, 515–522.
Brussard, JH, Lowik, MRH, Van den Berg, H, Brants, HAM & Kistemaker, C (1997) Micronutrient status, with special reference to vitamin B6. European Journal of Clinical Nutrition 51, Suppl. 3, S32–S38.
Bukoski, RD, DeWan, P & McCarron, DA (1989) 1,25 (OH)2 vitamin D3 modifies growth and contractile function of vascular smooth muscle of spontaneously hypertensive rats. American Journal of Hypertension 2, 533–556.
Bukoski, RD, Ishibashi, K & Bian, K (1995) Vascular actions of the calcium-regulating hormones. Seminars in Nephrology 15, 536–549.
Bukoski, RD & Kremer, D (1991) Calcium-regulating hormones in hypertension: vascular actions. American Journal of Clinical Nutrition 54, 220S–226S.
Bukoski, RD, Wagman, DW & Wang, D (1990) Injection of 1,25 vitamin D enhances resistance artery contractile properties. Hypertension 16, 523–531.
Bulpitt, CJ (1990) Vitamin C and blood pressure. Journal of Hypertension 8, 1071–1075.
Burgess, ED, Hawkins, RG & Watanabe, M (1990) Interaction of 1,25-dihydroxy vitamin D and plasma renin activity in high renin essential hypertension. American Journal of Hypertension 3, 903–905.
Burgess, E, Lewanczuk, R, Bolli, P, Chockalingam, A, Cutler, H, Taylot, G & Hamet, P (1999) Recommendations on potassium, magnesium and calcium. Canadian Medical Association Journal 160, Suppl. 9, S35–S45.
Campese, VM, Romoff, MS & Levitan, D (1982) Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney International 21, 371–378.
Canadian Recommendations for the Management of Hypertension (1999) Canadian Medical Association Journal 161, S1–S22.
Catterall, WA, Seage, MJ & Takahashi, M. (1998) Molecular properties of dihydropyridine-sensitive calcium channels in skeletal muscle. Journal of Biological Chemistry 263, 3535–3538.
Ceriello, A, Giugliano, D, Quatraro, A & Lefebvre, PJ (1991) Antioxidants show an antihypertensive effect in diabetics and hypertensive subjects. Clinical Science 81, 739–742.
Chen, CJ, Hsuek, Ym, Lai, MS, Shyu, MP, Chen, SY, Wu, MM, Kuo, TL & Tai, TY (1995) Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25, 53–60.
Chen, YF, Meng, Q & Wyss, JM (1988) High NaCl diet reduces hypothalamic norepinephrine turnover in hypertensive rats. Hypertension 11, 55–62.
Ciaraldi, TP, Kolterman, OG & Olefsky, JM (1981) Mechanism of the post-receptor defect in insulin action in human obesity. Decrease in glucose transport system activity. Journal of Clinical Investigation 68, 875–880.
Collier, A, Wilson, R, Bradley, H, Thomas, JA & Small, M (1990) Free radical activity in type II diabetes. Diabetic Medicine 7, 27–30.
Conti, CR (1999) Vitamin C and coronary vasoactivity. European Heart Journal 20, 1615–1617.
Corvol, MM, Ulman, A & Garabedian, M (1980) Specific nuclear uptake of 24,25-dihydroxycholecalciferol, a vitamin D3 metabolite biologically active in cartilage. FEBS Letters 116, 273–276.
Dahl, LK, Leitl, G & Heine, M (1972) Influence of dietary potassium and sodium/potassium molar ratios on the development of salt hypertension. Journal of Experimental Medicine 136, 318–330.
Dakshinamurti, K & Lal, KJ (1992) Vitamins and hypertension. World Review of Nutrition and Dietetics 69, 40–73.
Dakshinamurti, K, Lal, KJ, Dhalla, NS, Musat, S & Wang, Xi (2000) Pyridoxal 5-phosphate and calcium channels. In Biochemistry and Molecular Biology of Vitamin B6 and PQQ-dependent proteins pp. 307–314 [Iriarte, A, Kagan, HM and Martinez-Carrion, M editors]. Basel: Birkhauser Verlag.
Dakshinamurti, K, Lal, KJ & Ganguly, PK (1998) Hypertension, calcium channels and pyridoxine (vitamin B6). Molecular and Cellular Biochemistry 188, 137–148.
Dakshinamurti, K, Paulose, CS, Viswanathan, M, Siow, YL, Sharma, SK & Bolster, B (1990 a) Neurobiology of pyridoxine. Annals of the New York Academy of Sciences 585, 129–144.
Dakshinamurti, K, Sharma, SK & Bonke, D (1990 b) Influence of B vitamins on binding properties of serotonin receptors in the CNS of rats. Klinische Wochenschrift 68, 142–148.
de Bold, MLK, (1999) Estrogen, natriuretic peptides and the renin-angiotensin system. Cardiovascular Research 41, 524–531.
Dijkhorst-Oei, LT, Stross, ES, Koomans, HA & Rabelink, TJ (1999) Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo. Journal of Cardiovascular Pharmacology 33, 420–424.
Dominiczak, AF & Bohr, DF (1990) Cell membrane abnormalities and the regulation of intracellular calcium concentration in hypertension. Clinical Science 79, 415–423.
Drueke, TB (1999) Dietary calcium and blood pressure. American Journal of Hypertension 14, 96–98.
Dubyak, GR & El-Moatassium, C (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. American Journal of Physiology 265, C577–C606.
Duffy, SJ, Gokce, N, Holbrook, M, Huang, A, Frei, B, Kearney, JF Jr & Vita, JA (1999) Treatment of hypertension with ascorbic acid. Lancet 354, 2048–2049.
Ellis, JM & McCully, KS (1995) Prevention of myocardial infarction by vitamin B6. Research Communications in Chemical Pathology and Pharmacology 89, 208–220.
Erin, AN, Spirin, MM & Tabidze, LV (1984) Formation of α-tocopherol complex with fatty acids: a hypothetical mechanism of stabilization of biomembranes by vitamin E. Biochimica et Biophysica Acta 774, 96–102.
Evans, RJ & Kennedy, C (1994) Characterization of P2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses. British Journal of Pharmacology 113, 853–860.
Faure, P, Rossini, E, Lafond, JL, Richard, MJ, Favier, A & Halimi, S (1997) Vitamin E improves the free radical defence system potential and insulin sensitivity of rats fed high fructose diets. Journal of Nutrition 127, 103–107.
Feldman, EB, Gold, S, Green, J, Moran, J, Xu, G & Shultz, GG (1992) Ascorbic acid supplements and blood pressure. A four week pilot study. Annals of the New York Academy of Sciences 669, 342–344.
Ferrannini, E, Buzzigoli, G & Bonadonna, R (1987) Insulin resistance in essential hypertension. New England Journal of Medicine 317, 350–356.
Ferrante, J & Triggle, DJ (1990) Drug and disease-induced regulation of voltage-dependent calcium channels. Pharmacological Reviews 42, 29–44.
Fields, M (1999) Role of trace elements in coronary heart disease. British Journal of Nutrition 81, 85–86.
Fields, M, Lewis, CG, Lure, MD, Burns, WA & Antholine, WE (1993) Low dietary iron prevents free radical formation and heart pathology of copper-deficient rats fed fructose. Proceedings of the Society for Experimental Biology and Medicine 202, 225–231.
Flora, JS & Hara, K (1993) Sympathoneural and hemodynamic characteristics of young subjects with mild essential hypertension. Journal of Hypertension 11, 647–655.
Forte, P, Copland, M, Smith, LM, Milne, E, Sutherland, J & Benjamin, N (1997) Basal nitric oxide synthesis in essential hypertension. Lancet 349, 837–842.
Freedman, AM, Mark, IT, Stafford, RE, Dickens, BF, Cassidy, MM, Muesing, RA & Weglicki, WB (1992) Erythrocytes from magnesium-deficient hamsters display an enhanced susceptibility to oxidative stress. American Journal of Physiology 262, C1371–C1375
Galley, HF, Thornton, J, Howdle, PD, Walker, BE & Webster, NR (1997) Combination oral antioxidant supplementation reduces blood pressure. Clinical Science 9, 361–365.
Geleijnse, JM, Wittman, JCM, Back, AAA, den Breejen, JH & Grobbe, DE (1994) Reduction in blood pressure with a low sodium, high magnesium salt in older subjects with mild to moderate hypertension. British Medical Journal 309, 436–440.
Gemba, T, Ninomiya, M, Matsunaga, K & Veda, M (1992) Changes in extracellular concentration of amino acids in the hippocampus during cerebral ischemia in stroke-prone SHR, stroke-resistant SHR and normotensive rats. Neuroscience Letters 135, 184–188.
Gey, KF, Stahelin, HB & Eicholzer, M (1993) Poor plasma status of carotene and vitamin C is associated with a higher mortality from ischemic heart disease and stroke. Basal prospective study. Clinical Investigation 71, 3–6.
Ghosh, SK, Ekpo, EB, Shah, IU, Gerling, AJ, Jankins, C & Sinclair, AJ (1994) A double blind, placebo-controlled parallel trial of vitamin C treatment in elderly patients with hypertension. Gerontology 40, 268–272.
Glossman, H & Striessnig, J (1988) Calcium channels. Vitamins and Hormones 44, 155–328.
Gonic, HC, Ding, V, Bondy, SC & Vaziri, ND (1997) Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. Hypertension 30, 1487–1492.
Goody, HF, Purkins, L, Heatley, RV & Kelleher, J (1991) The effect of vitamin E deficiency on plasma zinc and copper concentrations. Clinical Nutrition 10, 233–235.
Grassi, G, Catteneo, BM, Seravalle, G, Lanfranchie, A & Mancia, G (1997) Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 31, 68–72.
Gratacos, E, Casals, E, Deulofen, R, Carrach, V, Alonso, PL & Fortuny, A (1998) Lipid peroxide and vitamin E patterns in pregnant women with different types of hypertension in pregnancy. American Journal of Obstetrics and Gynecology 178, 1072–1076.
Griffith, LE, Guyatt, GH, Cook, RJ, Bucher, HC & Cook, DJ (1999) The influence of dietary and non dietary calcium supplementation on blood pressure. American Journal of Hypertension 14, 84–92.
Grimm, RH, Neaton, JD & Elmer, PJ (1990) The influence of oral potassium chloride on blood pressure in hypertensive men on a low sodium diet. New England Journal of Medicine 322, 569–574.
Groop, L, Ekstrand, A & Forsblom, C (1993) Insulin resistance, hypertension and microalbuminuria in patients with type 2 diabetes mellitus. Diabetologia 36, 642–647.
Groop, L, Forsblom, C & Lehtovirta, M (1996) Metabolic consequences of a family history of NIDDM (the Botnia Study): evidence of sex-specific parental effects. Diabetes 45, 1585–1593.
Groop, L, Forsblom, C & Lehtovirta, M (1997) Characterization of the prediabetic state. American Journal of Hypertension 10, 172S–180S.
Groz, G, Hantt, G & Kolassa, N (1987) Urapidil and some analogs with hypotensive properties show high affinities for 5-HT binding sites of the 5 HT1A subtype and for α1-adrenoreceptor binding sites. Naunyn-Schmiedeberg's Archives of Pharmacology 336, 597–601.
Haffner, SM, Ferrannini, E, Hazuda, HP & Stern, MP (1992 a) Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 20, 38–45.
Haffner, SM, Miettinen, H, Gaskill, SP & Stern, MP (1992 b) Metabolic precursors of hypertension. Archives of Internal Medicine 156, 1994–2001.
Haffner, SM, Valdez, RA, Hazuda, HP, Mitchel, BD, Morales, PA & Stern, MP (1996) Prospective analyses of the insulin resistance syndrome (syndrome X). Diabetes 41, 715–722.
Hatton, IC & McCarron, DA (1994) Dietary calcium and blood pressure in experimental models of hypertension. Hypertension 23, 513–530.
Holtback, U, Kruse, MS, Brismar, H & Aperia, A (2000) Intrarenal dopamine co-ordinates the effects of antinatriuretic and natriuretic factors. Acta Physiologica Scandinavica 168, 215–218.
Hourani, SMO, Loizon, GD & Cusak, NJ (1986) Pharmacological effects of L-AMP-PCP on ATP receptors in smooth muscle. European Journal of Pharmacology 131, 99–103.
Huang, BS & Leenen, FHH (1996) Sympathoexcitatory and pressor responses to increased brain sodium and oubain are mediated via brain ANG II. American Journal of Physiology 270, H275–H280
Istfan, NW, Plaisted, CS & Bistrain, BR (1992) Insulin resistance versus insulin secretion in the hypertension of obesity. Hypertension 19, 385–392.
Jacques, PF (1992) Relationship of vitamin C status to cholesterol and blood pressure. Annals of the New York Academy of Sciences 669, 205–214.
Janero, DR & Burghardt, B (1988) Myocardial vitamin E (α-tocopherol) contents of SHR & WKY normal rats. International Journal of Vitamin and Nutrition Research 58, 292–294.
Jeserich, M, Schindler, T, Olscherwski, M, Unmussig, M, Just, H & Solzback, U (1999) Vitamin C improves endothelial function of epicardial coronary arteries in patients with hypercholesterolemia or essential hypertension - assessed by cold pressor testing. European Heart Journal 20, 1676–1680.
Jespersen, B, Randlov, A, Abrahamsen, J, Fogh-Anderson, J, Olsen, NV & Kanstrup, I-L (1998) Acute cardiovascular effects of 1,25-dihydroxycholecalciferol in essential hypertension. American Journal of Hypertension 11, 659–666.
John, S & Schmieder, RE (2000) Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. Journal of Hypertension 18, 363–374.
Julius, S (1996) The evidence for a pathophysiologic significance of the sympathetic overactivity in hypertension. Clinical and Experimental Hypertension 18, 305–321.
Julius, S, Gundbrandsson, T, Jamerson, K & Andersson, O (1992) The interconnection between sympathetics, microcirculation and insulin resistance in hypertension. Blood Pressure 1, 9–19.
Kanai, H, Matsuzawa, Y & Togunaga, K (1990) Hypertension in obese children: fasting serum insulin levels are closely correlated with blood pressure. International Journal of Obstetrics 14, 1047–1056.
Kawano, Y, Matsuoka, H, Takshita, S & Omae, T (1998) Effect of magnesium supplementation in hypertensive patients. Assessment by office, home and ambulatory blood pressure. Hypertension 32, 260–265.
Kawashima, H (1987) Receptor for 1,25 dihydroxy-vitamin D in a vascular cell line derived from rat aorta. Biochemical Biophysical Research Communications 146, 1–6.
Kesteloot, H & d Geboers, J (1982) Calcium and blood pressure. Lancet 1, 813–815.
Khalil-Manesh, F, Gonic, HC, Weiler, FW, Prin, B, Weber, MA, Purdy, R & Reno, Q (1994) Effect of chelation treatment with dimercapto succinic acid on lead-related blood pressure changes. Environmental Research 65, 86–99.
Khaw, KT & Barrett-Connor, E (1987) Dietary potassium and stroke-associated mortality: a 12-year prospective population study. New England Journal of Medicine 316, 235–240.
Kokubun, S & Reuter, H (1984) Dihydropyridine derivatives prolong the open state of calcium channels in cultured cardiac cells. Proceedings of the National Academy of Sciences USA 81, 4824–4827.
Krause, S, Buhring, M, Hopfen Muller, W, Holick, MG & Sharma, AM (1998) Ultraviolet B and blood pressure. Lancet 352, 709–710.
Krishna, GG (1990) Effect of potassium intake on blood pressure. Journal of the American Society of Nephrology 39, 771–776.
Krishna, GG (1994) Role of potassium in the pathogenesis and treatment of hypertension. American Journal of Medical Sciences 307, S21–S25.
Kugiyama, K, Motoyama, T & Hiroshima, O (1998) Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteris in patients with coronary spastic angina. Journal of the American College of Cardiology 32, 103–109.
Lal, KJ & Dakshinamurti, K (1993 a) Hypotensive action of 5-HT receptor agonists in the vitamin B6 deficient hypotensive rat. European Journal of Pharmacology 234, 183–189.
Lal, KJ & Dakshinamurti, K (1993 b) Calcium channels in vitamin B6 deficiency-induced hypertension. Hypertension 11, 1357–1362.
Lal, KJ & Dakshinamurti, K (1995) Relationship between low calcium induced hypertension and vitamin B6 status. Journal of Hypertension 13, 327–332.
Lal, KJ, Dakshinamurti, K & Thliveris, J (1996) The effect of vitamin B6 on the systolic blood pressure of rats in various animal models of hypertension. Journal of Hypertension 14, 355–363.
Lal, KJ, Sharma, SK & Dakshinamurti, K (1993) Regulation of calcium influx into vascular smooth muscle by vitamin B6. Clinical and Experimental Hypertension 15, 489–500.
Laurant, P, Dalle, M, Berthelot, A & Rayssiguier, Y (1999) Time-course of the change in blood pressure level in magnesium-deficient Wistar rats. British Journal of Nutrition 82, 243–251.
Lee, CN, Reed, DM, MacLean, CJ, Yano, K & Chin, D (1988) Dietary potassium and stroke. New England Journal of Medicine 318, 995–996.
Levine, GN, Frei, B, Koulouris, SN, Gerhard, MD, Kearney, JF & Vita, JA (1996) Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 93, 1107–1113.
Lin, H & Young, DB (1994) Interaction between plasma potassium and epinephrine in coronary thrombosis in dogs. Circulation 89, 331–338.
Linas, SL (1991) The role of potassium in the pathogenesis and treatment of hypertension. Kidney International 39, 771–789.
Lind, L, Wengle, B, Wide, L & Ljunghall, S (1989) Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status: a double-blind, placebo- controlled study. American Journal of Hypertension 2, 20–25.
Litwack, G (1988) The glucocorticoid receptor at the protein level. Cancer Research 48, 2636–2640.
Lovat, LB, Lu, Y, Palmer, AJ, Edwards, R, Fletcher, AE & Bulpit, CJ (1993) Double blind trial of vitamin C in elderly hypertensives. Journal of Human Hypertension 7, 403–405.
Lucas, MJ, Leveno, KJ & Cunningham, FG (1995) A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. New England Journal of Medicine 333, 201–205.
Lyons, D, Webster, J & Benjamin, N (1994) The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension. Journal of Hypertension 14, 1047–1052.
McCabe, RD, Backarich, MA, Srivastava, K & Young, DB (1994) Potassium inhibits free radical formation. Hypertension 24, 77–82.
McCabe, RD & Young, DB (1994) Potassium inhibits cultured vascular smooth muscle proliferation. American Journal of Hypertension 7, 346–350.
McCarron, DA (1985) Is calcium more important than sodium in the pathogenesis of essential hypertension? Hypertension 7, 607–627.
McCarron, DA (1998) Diet and blood pressure - the paradigm shift. Science 281, 933–934.
McCarron, DA, Morris, CD, Henry, HJ & Stanton, JL (1984) Blood pressure and nutrient intake in the United States. Science 224, 1392–1398.
McCarron, DA, Oparil, S, Chait, Ä, Haynes, RB, Kris-Etherton, P, Stern, JS, Resnick, LM, Clark, S, Morris, CD, Hatton, DC, Metz, JA, McMohan, M, Holcomb, S, Snyder, GW & Pi-Sunyer, FX (1997) Nutritional management of cardiovascular risk factors. A randomized clinical trial. Archives of Internal Medicine 153, 154–183.
McCarron, DA, Oparil, S, Resnick, LM, Chait, A, Haynes, B, Kris-Etherton, P, Pi-Sunyer, FX, Stern, JS, Morris, CD, Clark, S, Hatton, DC, Metz, JA, McMohan, M, Holcomb, S & Snyder, GW (1998) Comprehensive nutrition plan improved cardiovascular risk factors in essential hypertension. American Journal of Hypertension 11, 31–40.
McCarron, DA & Reusser, ME (1999) Finding consensus in the dietary calcium-blood pressure debate. Journal of the American College of Nutrition 18, 398S–405S.
Machlin, IJ & Bendich, A (1987) Free radical tissue damage: protective role of antioxidant nutrients. FASEB Journal 1, 441–445.
MacMahon, SW, MacDonald, GJ & Blacket, RB (1985) Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. Arteriosclerosis 67, 49–55.
Maier, LS, Brandes, R, Pieske, B & Bers, DM (1998) Effects of left ventricular hypertrophy on force and Ca2+ handling in isolated rat myocardium. American Journal of Physiology 274, H1361–H1370
Malluche, HH, Henry, H, Meyer-Saballek, W, Sherman, S, Massry, SG & Norman, AN (1980) Effects and interactions of 24,25 (OH)2 D3 and 1,25 (OH)2 D3 on bone. American Journal of Physiology 238, E494–E496
Manicardi, V, Camellini, L & Bellodi, G (1986) Evidence for an association of high blood pressure and hyperinsulinemia in obese man. Journal of Clinical Endocrinology and Metabolism 62, 1302–1304.
Mancia, G (1997) The sympathetic nervous system in hypertension. Journal of Hypertension 15, 1553–1565.
Massry, SG, Iseki, K & Campese, VM (1986) Serum calcium, parathyroid hormone and blood pressure. American Journal of Nephrology 6, 1–28.
Merke, J & Norman, AW (1981) Evidence of 24 (R) 25(OH)2 D3 receptor on the parathyroid gland of rachitic chicken. Biochemical and Biophysical Research Communications 100, 551–558.
Metz, JA, Morris, CD, Roberts, LA, McClung, MR & McCarron, DA (1999) Blood pressure and calcium intake are related to bone density in adult males. British Journal of Nutrition 81, 383–388.
Minghetti, PP & Norman, AW (1988) 1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry. FASEB Journal 2, 3043–3053.
Mizushima, S, Cappuccio, FP, Nichols, R & Elliot, P (1998) Dietary magnesium intake and blood pressure: a qualitative overview of observational studies. Journal of Human Hypertension 14, 447–453.
Morales, PA, Mitchell, BD, Valdez, RA, Hazuda, HP, Stern, MP & Haffner, SM (1993) Incidence of non-insulin dependent diabetes mellitus and impaired glucose tolerance in hypertensive subjects: the San Antonio Heart Study. Diabetes 42, 154–163.
Moran, JP, Cohen, L, Green, JM, Xu, G, Feldman, EB & Hames, CG (1993) Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. American Journal of Clinical Nutrition 57, 213–217.
Moser, M (1999) National recommendations for the pharmacological treatment of hypertension. Archives of Internal Medicine 159, 1403–1406.
MRC/BHF (1999) Heart protection study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. European Heart Journal 20, 725–741.
Murray, ED Jr, Wechter, WJ, Kantochi, D, Wang, W-H, Pham, T, Quiggle, DD, Gibson, KM, Leipold, D & Anner, BM (1997) Endogenous natriuretic factors 7: Biospecificity of a natriuretic δ-tocopherol metabolite LLU-α. Journal of Pharmacology and Experimental Therapeutics 282, 657–662.
Mykkanen, L, Kuusisto, J, Pyorala, K, Laasko, M & Haffner, SM (1994) Increased risk of non-insulin dependent diabetes mellitus in elderly hypertensive subjects. Journal of Hypertension 14, 1425–1432.
Nasir, F, Mazure, A, Gionnoni, F, Gueux, E, Davidson, O & Rayssiguer, Y (1995) Magnesium deficiency modulates hepatic lipogenesis and apolipoprotein gene expression in the rat. Biochimica et Biophysica Acta 1257, 125–132.
Nelson, D & Taylor, WE (1986) A selective serotonin1A receptor agonist. European Journal of Pharmacology 124, 207–208.
Ness, AR, Khaw, KT, Bingham, S & Day, NE (1996) Vitamin C status and blood pressure. Journal of Hypertension 14, 503–508.
Newaz, MA & Nawal, NNA (1998) Effect of α-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats. American Journal of Hypertension 11, 1480–1485.
Newaz, MA, Nawal, NNA, Rohaizan, CH, Muslim, N & Gapor, A (1999) α-Tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats. American Journal of Hypertension 14, 839–844.
Ng, LL, Ngkeekwong, FC, Quinn, PA & Davies, JE (1998) Uptake mechanisms for ascorbate and dehydroascorbate in lymphoblasts from diabetic nephropathy and hypertensive patients. Diabetologia 41, 435–442.
Ngheim, CX & Rapp, JP (1983) Responses to calcium of chemically skinned vascular smooth muscle from spontaneously hypertensive rats. Clinical and Experimental Hypertension 4, 849–856.
Nosadini, R, Solini, A, Velussi, M, Muollo, B, Frigato, F, Sambataro, M, Cipollina, MR, DeRiva, F, Brocco, I & Crepaldi, G (1994) Impaired insulin-induced glucose uptake by extra hepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes 43, 491–499.
Nowack, R, Wiecer, A, Exner, B, Gretz, N & Ritz, E (1993) Chronic lead exposure in rats: effects on blood pressure. European Journal of Clinical Investigation 23, 433–448.
Nurminen, M-L, Korpela, R & Vapaatalo, H (1998) Dietary factors in the pathogenesis and treatment of hypertension. Annals of Medicine 30, 143–150.
O'Hare, JA, Minaker, KL & Meneilly, GS (1989) Effect of insulin on plasma norepinephrine and 3,4 dihydroxy-phenylalanine in obese men. Metabolism 38, 322–329.
Overback, A, Zenzen, JG, Ressel, C, Muller, HM & Stumpe, KO (1987) Influence of magnesium on blood pressure and the effect of nifedipine in rats. Hypertension 9, 139–143.
Palozza, P & Krinsky, NI (1992) Beta carotene and alpha tocopherol are synergistic antioxidants. Archives of Biochemistry and Biophysics 297, 184–187.
Pang, PKT & Lewanczuk, RZ (1989) Parathyroid origin of a new circulating hypertensive factor in spontaneously hypertensive rats. American Journal of Hypertension 2, 898–902.
Pang, PKT, Narvey, S & Doris, PA (1987) Plasma parathyroid hormone during the development of spontaneous hypertension in rats. Canadian Journal of Physiology and Pharmacology 65, 2386–2389.
Paolisso, G & Barbagallo, M (1997) Hypertension, diabetes mellitus and insulin resistance. The role of intracellular magnesium. American Journal of Hypertension 10, 346–355.
Paolisso, G, DiMaro, G & Cozzolino, B (1992 a) Chronic magnesium administration enhances oxidative glucose metabolism in thiazid treated hyperensive patients. American Journal of Hypertension 5, 681–686.
Paolisso, G, DiMaro, G, Pizza, G, D'Amore, A, Scambato, S, Tesauro, P, Varricchio, M & d'Onofrio, F (1992 b) Plasma GHS/GSSG affects glucose homeostasis in healthy subjects and non-insulin dependent diabetics. American Journal of Physiology 263, E435–E440
Paulose, CS & Dakshinamurti, K (1987) Chronic catheterization using vascular access port in rats: blood sampling with minimal stress for plasma catecholamine determination. Journal of Neuroscience Methods 22, 141–146.
Paulose, CS, Dakshinamurti, K, Packer, S & Stephens, NL (1986) Hypertension in pyridoxine deficiency. Journal of Hypertension 4, Suppl. 5, S174–S175.
Paulose, CS, Dakshinamurti, K, Packer, S & Stephens, NL (1988) Sympathetic stimulation and hypertension in the pyridoxine-deficient adult rat. Hypertension 11, 387–391.
Postnor, YP & Orlov, SN (1985) Ion transport across phasma in primary hypertension. Physiological Reviews 65, 904–905.
Rahman, M, Tondel, M, Ahmed, SA, Chowdhury, IA, Faruquee, MH & Axelson, O (1999) Hypertension and arsenic exposure in Bangladesh. Hypertension 33, 74–78.
Rahn, KH, Barenbrock, M & Hausberg, M (1999) The sympathetic nervous system in the pathogenesis of hypertension. Journal of Hypertension 17, Suppl. 3, S11–S14.
Rappaport, A, Sturtz, F & Guicheney, P (1985) Regulation of central α-adrenoreceptor by serotonergic denervation. Brain Research 344, 158–161.
Rapp, JP, Nghiem, CX & Oniwochi, MO (1986) Aortic calcium uptake and efflux in spontaneously hypertensive and inbred Dahl rats. Journal of Hypertension 4, 493–499.
Rayssiguier, Y, Durlach, J, Gueux, E, Rock, E & Mazur, A (1993 a) Magnesium and aging: experimental data—importance of oxidative damage. Magnesium Research 3, 369–378.
Rayssiguier, Y, Gueux, E, Bussiere, L, Durlach, J & Mazur, A (1993 b) Dietary magnesium affects susceptibility of lipoproteins and tissue to peroxidation in rats. Journal of the American College of Nutrition 14, 133–137.
Reaven, GR & Hoffman, BB (1988) Abnormalities of carbohydrate metabolism may play a role in the etiology and clinical course of hypertension. Trends in Pharmacological Science 9, 78–79.
Repke, JT, Villar, J, Anderson, C, Pareja, G, Dubin, N & Belizan, JM (1989) Biochemical changes associated with blood pressure reduction induced by calcium supplementation during pregnancy. American Journal of Obstetrics and Gynecology 160, 684–690.
Resnick, LM (1999 a) The cellular ionic basis of hypertension and allied clinical conditions. Progress in Cardiovascular Diseases 42, 1–22.
Resnick, LM (1999 b) Therapeutic implications of calcium intake in hypertension. American Journal of Hypertension 14, 82–83.
Resnick, LM (1999 c) The role of dietary calcium in hypertension. American Journal of Hypertension 14, 99–112.
Resnick, LM, Gupta, RK & Laragh, JH (1984) Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proceedings of the National Academy of Sciences USA 81, 6511–6515.
Resnick, LM & Laragh, J (1985) Calcium metabolism and parathyroid function in primary aldosteronism. American Journal of Medicine 78, 385–390.
Resnick, LM, Laragh, J, Sealey, J & Alderman, M (1983) Divalent cations in essential hypertension: relations between serum ionized calcium, magnesium and plasma renin activity. New England Journal of Medicine 309, 888–891.
Resnick, LM, Lewanczuk, RZ, Laragh, JH & Pang, PKT (1993) Parathyroid hypertensive factor-like activity in human essential hypertension. Relationship to plasma renin activity and dietary salt sensitivity. Journal of Hypertension 11, 1235–1241.
Resnick, LM, Militianu, DM & Cunnings, AJ (1997) Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium. Hypertension 30, 654–659.
Reusser, ME & McCarron, DA (1994) Micronutrient effects on blood pressure regulation. Nutrition Reviews 52, 367–375.
Ribaya Mercado, JD, Russel, RM, Sayhoun, N, Morrow, FD & Gershoff, SN (1991) Vitamin B6 requirements of elderly men and women. Journal of Nutrition 121, 1062–1074.
Rockstroh, JK, Schobel, HP & Vogt-Ladner, G (1997) Blood pressure independent effects of nitrendipine on cardiac structure in patients after renal transplantation. Nephrology, Dialysis and Transplantation 14, 1441–1447.
Ross, R (1986) The pathogenesis of atherosclerosis: an update. New England Journal of Medicine 314, 488–500.
Rostand, SG (1997) Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30, 150–156.
Rowe, JW, Young, JB & Minaker, KL (1981) Effect of insulin and glucose infusion on sympathetic nervous system activity in normal man. Diabetes 30, 219–225.
Sacks, FM, Willet, WC, Smith, AM, Brown, LE, Rosner, B & Moore, TJ (1998) Effect on blood pressure of potassium, calcium and magnesium in women with low habitual intake. Hypertension 31, 131–138.
Sacks, FM, Obarzanek, E & Windhauser, MM (1995) Rationale and design of the dietary approaches to stop hypertension trial (DASH): a multicentered controlled-feeding study of dietary patterns to lower blood pressure. Annals of Epidemiology 5, 108–118.
Sagar, S, Kallo, U, Kaul, N, Ganguly, NK & Sharma, BK (1992) Oxygen free radicals in essential hypertension. Molecular and Cellular Biochemistry 111, 103–108.
Saito, K, Sano, H, Furuta, Y & Fukuzaki, H (1989) Effect of oral calcium on blood pressure response in salt loaded borderline hypertensive patients. Hypertension 13, 219–226.
Sallinen, K, Arvola, P, Wuorela, H, Ruskoaho, H, Vapaatalo, H & Porsti, I (1996) High calcium diet reduces blood pressure in exercised and nonexercised hypertensive rats. American Journal of Hypertension 9, 144–156.
Salonen, R, Korpela, H, Nyyssonen, K, Porkkala, E & Salonen, JT (1994) Reduction of blood pressure by antioxidant supplementation: a randomized double-blind clinical trial. Life Chemistry Reports 14, 65–68.
Schleiffer, R, Pernot, F & Gairard, A (1986) Parathyroidectomy, cardiovascular reactivity and calcium distribution in aorta and heart of spontaneously hypertensive rats. Clinical Science 71, 505–511.
Schmid, A, Renaud, J & Luxdunski, M (1985) Short term and long term effects of β adrenergic effectors and cyclic AMP on nitrendipine-sensitive voltage-dependent Ca2+ channels of skeletal muscle. Journal of Biological Chemistry 260, 13041–13046.
Schoeffler, P & Hoyer, D (1988) Centrally acting hypotensive agents with affinity for 5HT1A binding sites inhibit forskolin-stimulated adenyl cyclase activity in calf hippocampus. British Journal of Pharmacology 95, 975–985.
Schroeder, HA (1960) Relations between mortality from cardiovascular disease and treated water supplies. Variations in sites and 163 largest municipalities of the United States. Journal of the American Medical Association 172, 1902–1908.
Shan, J, Bing, L, Taniguchi, N & Pang, PKT (1996) Inhibition of membrane L-type calcium channel activity and intracellular calcium concentration by 24 R, 25-dihydroxyvitamin D3 in vascular smooth muscle. Steroids 61, 657–663.
Shan, J, Resnick, LM, Lewanczuk, RZ, Karpinski, E, Li, B & Pang, PKT (1993) 1,25-Dihydroxyvitamin D as a cardiovascular hormone. American Journal of Hypertension 6, 983–988.
Shan, J, Resnick, LM, Liu, Q, Wu, X, Barbagallo, M & Pang, PKT (1994) Vascular effects of 17β-estradiol in male Sprague-Dawley rats. American Journal of Physiology 266, H967–H973
SHEP Cooperative Research Group Clinical Trials Branch (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in Elderly Program (SHEP). Journal of the American Medical Association 265, 3255–3264.
Sherman, DL, Keanney, JF, Biegelsen, ES, Duffy, SJ, Coffman, JD & Vita, JA (2000) Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 35, 936–941.
Shetterly, SM, Rewars, M, Hamman, R & Marshall, JA (1994) Patterns and predictors of hypertension incidence among hispanics and nonhispanic whites: the San Luis Valley Diabetes Study. Journal of Hypertension 14, 1095–1102.
Slater, TF (1984) Free radical mechanisms in tissue injury. Biochemical Journal 222, 1–15.
Solzbach, U, Hornig, B, Jeserich, M & Just, H (1997) Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 96, 1513–1519.
Somjen, D, Somjen, GJ, Harell, A, Mechanic, GL & Binderman, I (1982 a) Partial characterization of a specific high affinity binding macromolecule for 24 R, 25-dihydroxyvitamin D3 in differentiating skeletal mesenchyme. Biochemical and Biophysical Research Communications 106, 664–651.
Somjen, D, Somjen, GJ, Weisman, Y & Binderman, I (1982 b) Evidence for 24,25-dihydroxycholecalciferol receptors in long bones of new born rats. Biochemical Journal 204, 31–36.
Spangler, JG, Bell, R & Summerson, JH (1998) Hyperinsulinemia in hypertension. Association with race, abdominal obesity and hyperlipidemia. Archives of Family Medicine 7, 53–56.
Stadler, M, Pometta, D & Suenram, A (1981) Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men. Diabetologia 21, 544–548.
Standley, PR, Zhang, F, Ram, JL, Zemel, MB & Sowers, JR (1991) Insulin attenuates vasopressin-induced calcium transient and voltage-dependent calcium current in rat vascular smooth muscle cells. Journal of Clinical Investigation 88, 1230–1236.
Suter, PM (1998) Potassium and hypertension. Nutrition Reviews 56, 151–153.
Taddei, S, Virdis, A, Ghiadoni, L, Magagna, A & Salvetti, A (1998) Vitamin C improves endothelium-dependent vaso- dilation by restoring nitric oxide activity in essential hypertension. Circulation 97, 2222–2229.
Tagami, M, Ikeda, K, Nara, Y, Kubota, A, Numano, F & Yamori, Y (1997 a) Insulin-like growth factor-1 attenuates apotosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats. Laboratory Investigation 74, 613–617.
Tagami, M, Ikeda, K, Yamagata, K, Nara, Y, Fujino, H, Kubota, A, Numano, F & Yamori, Y (1999) Vitamin E prevents apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats. Laboratory Investigation 79, 609–615.
Tagami, M, Yamagata, K, Mara, Y, Kubota, A, Numano, F & Yamori, Y (1997 b) Insulin-like growth factors prevent apoptosis in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Laboratory Investigation 74, 603–612.
Taylor, AE (1996) Cardiovascular effects of environmental chemicals. Otolaryngology and Head and Neck Surgery 114, 209–211.
The Eclampsia Trial Collabrative Group (1995) Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 345, 1455–1463.
The Fifth Report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (1993) Archives of Internal Medicine 153, 154–183.
The Intersalt Cooperative Research Group (1988) Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24-hour urinary sodium and potassium. British Medical Journal 297, 319–328.
The Sixth Report of the Joint National Committee on detection, evaluation an d treatment of high blood pressure (1997) Archives of Internal Medicine 157, 2413–2446.
Thierry-Palmer, M, Carlyl, KS, Williams, MD, Tewolde, T, Caines-Mckenzie, S, Bayrog, MA, Emmett, NL, Harris-Hooker, SA, Sanford, GL & Williams, EF (1998) Plasma 25-hydroxyvitamin D concentrations are inversely associated with blood pressure of Dahl salt-sensitive rats. Journal of Steroid Biochemistry and Molecular Biology 66, 255–261.
Third Report on Nutrition Monitoring in the United States (1995) Volume 1. Washington DC: US Government Printing Office.
Ting, HH, Timimi, FK, Boles, KS, Creager, SJ, Ganz, P & Creageter, MA (1996) Vitamin C improves endothelium- dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 97, 22–28.
Tobian, L (1986) High potassium diets markedly protect against stroke deaths and kidney disease in hypertensive rats, a possible legacy from prehistoric times. Canadian Journal of Physiology and Pharmacology 64, 840–848.
Tobian, L, Lange, JM, Ulm, KM, Wold, IJ & Iwai, J (1984) Potassium prevents death from strokes in hypertensive rats without lowering blood pressure. Journal of Hypertension 2, Suppl., 363–366.
Touyz, RM, Tolloczko, B & Schiffrin, EL (1994) Insulin attenuates agonist-evoked calcium transients in vascular smooth muscle cells. Hypertension 23, Suppl., 125–128.
Trezise, DJ, Bell, NJ, Khakh, BS, Michael, AD & Humphrey, PA (1994) P2 purinoceptor antagonist properties of pyridoxal 5-phosphate. European Journal of Pharmacology 259, 295–300.
Trials of Hypertension Prevention Collaborative Research Group (1992) The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, phase 1. Journal of the American Medical Association 267, 1213–1220.
Tully, DB, Allgood, VE & Cidlowski, JA (1994) Modulation of steroid receptor-mediated gene expression by vitamin B6. FASEB Journal 8, 343–349.
Vallance, P, Collier, J & Moncada, S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2, 997–1000.
Van den Berg, H (1999) Vitamin B6 status and requirements in older adults. British Journal of Nutrition 81, 175–176.
Van der Wielen, RPJ, Lowik, MRH, Haller, J, Van den Berg, H, Ferry, M & Van Staveren, WA (1996) Vitamin B6 malnutrition among elderly Europeans: the SENECA study. Journal of Gerontology 51, B417–B424.
Vane, JR, Aggard, EE & Botting, RM (1990) Regulatory functions of the vascular endothelium. New England Journal of Medicine 323, 27–36.
Vanhoutte, PM (1999) How to assess endothelial function in human blood vessels. Journal of Hypertension 17, 1047–1058.
Vaziri, ND, Liang, K & Ding, Y (1999) Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney International 56, 1492–1498.
Vermaak, WH, Barnard, H, Potgieter, GM & Theron, H (1987) Vitamin B6 and coronary artery disease. Epidemiological observations and case studies. Atherosclerosis 63, 235–238.
Viswanathan, M, Bose, R & Dakshinamurti, K (1991) Increased calcium influx in caudal artery of rats made hypertensive with pyridoxine deficiency. American Journal of Hypertension 4, 252–255.
Viswanathan, M, Paulose, KJ, Lal, KJ & Dakshinamurti, K (1990) Alterations in brain stem α adrenoreceptor activity in pyridoxine-deficient rat model of hypertension. Neuroscience Letters 111, 201–205.
Vulchanova, L, Arvidsson, U, Riedi, M, Wang, J, Bull, G, Suprenant, A & North, RA (1996) Differential distribution of two ATP-gated ion channels (P2X receptors) determined by immunocytochemistry. Proceedings of the National Academy of Sciences USA 93, 8063–8067.
Wang, TM, Hsu, JF, Lee, WSS & Mathews, JL (1993) Evidence for reduced cancellous bone mass in the spontaneously hypertensive rat. Bone and Mineral 20, 251–264.
Wang, X, Dakshinamurti, K, Musat, S & Dhalla, NS (1999) Pyridoxal 5-phosphate is an ATP-receptor antagonist in freshly isolated rat cardiomyocytes. Journal of Molecular and Cellular Cardiology 31, 1063–1072.
Weglicki, WB, Mak, IT, Kramer, JH, Dickens, BF, Cassidy, MM, Stafford, RE & Phillips, TM (1996) Role of free radicals and substance P in magnesium deficiency. Cardiovascular Research 31, 677–682.
Weinberger, MH (1996) Salt sensitivity of blood pressure in humans. Hypertension 27, 481–490.
Wen, Y, Killalea, S, McGettigan, P & Feely, J (1996) Lipid peroxidation and antioxidant vitamin C and E in hypertensive patients. Irish Journal of Medical Sciences 165, 210–212.
Widgren, BR, Herlitz, H & Wikstrand, J (1992) Increased waist/hip ratio, metabolic disturbances, and family history of hypertension. Hypertension 20, 563–568.
Widman, L, Wester, PO, Stegmayr, BG & Wirell, MP (1993) The dose dependent reduction in blood pressure through administration of magnesium: a double blind placebo controlled cross-over trial. American Journal of Hypertension 6, 41–45.
Witteman, JCM, Willett, WC & Stampfer, MJ (1989) A prospective study of nutritional factors and hypertension among US women. Circulation 80, 1320–1327.
Woods, KL & Fletcher, S (1994) Long-term outcome after intravenous magnesium sulfate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial. Lancet 343, 816–819.
Xue, H, McCarron, DA & Bukoski, RD (1991) 1,25 (OH)2 vitamin D3 attenuates the loss of resistance artery contractile function associated with incubation in cultured media. Biochemical and Biophysical Research Communications 174, 11–17.
Yang, CY (1998) Calcium and magnesium in drinking water and risk of death from cerebrovascular disease. Stroke 29, 411–414.
Yoshioka, M, Aoyama, K & Matsushita, T (1985) Effects of ascorbic acid on blood pressure and ascorbic acid metabolism in spontaneously hypertensive rats. International Journal of Vitamin and Nutrition Research 55, 301–307.
Yoshioka, S, Nishino, H, Shiraki, T, Ikeda, K, Koike, H & Okuno, A (1993) Antihypertensive effects of Cs-045 treatment in obese Zucker rats. Metabolism 42, 75–80.
Young, DB, Lin, H & McCabe, RD (1995) Potassium's cardiovascular protective mechanisms. American Journal of Physiology 268, R825–R837.
Zein, M, Areas, JL & Preus, HG (1990) Long-term effects of excess sucrose ingestion on three strains of rats. American Journal of Hypertension 3, 560–562.
Zemel, MB (1995) Insulin resistance, obesity and hypertension: an overview. Journal of Nutrition 125, 1715S–1717S.
Zemel, MB (1998) Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension. Molecular and Cellular Biochemistry 188, 129–136.
Zemel, M, Gualdoni, S & Walsh, M (1986) Effects of sodium and calcium on calcium metabolism and blood pressure regulation in hypertensive black adults. Journal of Hypertension 4, Suppl. 5, S364–S365.
Zemel, MB, Johnson, BA & Ambrozy, SA (1992 a) Insulin-stimulated vascular relaxation: Role of Ca2+-ATPase. American Journal of Hypertension 5, 637–641.
Zemel, MB, Peuler, JD, Sowers, JR & Simpson, L (1992 b) Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support. American Journal of Physiology 262, E368–E371
Ziemalanski, S, Wartanowicz, M, Potribnicka, K, Burgos de Moor, A, Iwanow, K & Ignatowska-Switalska, M (1991) Effect of exogenous ascorbic acid on experimental hypertension and mineral balance in rats fed low-and high-fat diets. Nutrition 7, 131–135.